-
Recent Posts:
Recent Comments:
Latest PLoG Posts
- World Hepatitis Day 2014 – Think Again in Work In Progress
- Visit PLOS at IUMS 2014 in Montréal in Work In Progress
- The Relationships of Education, Health, and Skills in Improving the Lives of Adults and Their Families: A Call for Papers for a New PLOS Collection in Work In Progress
- Immigrant youth to Canada are less active than Canadians, but only for a little bit in Work In Progress
- Just Add Water: World Water Monitoring Challenge 2013 Results in Work In Progress
You may also be interested in:
Click to go to this PLOS Medicine collection
Blog Archives
Cancer Care’s “Culture of Excess”
Category: cancer, Cost-Effectiveness Analysis, Healthcare
Tagged biomarkers, cancer, cancer care, cancer cost, complex adaptive systems, European Multidisciplinary Cancer Congress, FiercePharma, incremental cost-effectiveness ratios, moral hazard, Richard Sullivan, The Huffington Post, The Lancet Oncology
3 Comments
Jessica Wapner is a freelance writer focused mainly on biomedical issues. Her work is published in Scientific American, The New York Times, Slate, Science, Nature Medicine, and elsewhere. Her first book, The Philadelphia Chromosome is forthcoming from The Experiment in May 2013.